Topics
Glioblastoma | Treatment | Targeted therapy | Belzutifan
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Belzutifan
Strowd RE, de la Fuente M, Bauer TM, Papadopoulos KP, Chen K,
Perini RF, Liu Y, McDermott DF.
Phase
1 LITESPARK-001 study of belzutifan in participants with advanced
solid tumors: Results of the glioblastoma expansion cohort.
Neurooncol
Adv. 2025 Nov 20;8(1):vdaf242. doi:
10.1093/noajnl/vdaf242. PMID:
42058763. Trial
registration ID: NCT02974738. ˍ